Intravenous phosphatidylcholine supports arterial plaque management and restores membrane quality across tissues. PC is a primary membrane phospholipid that also supports fat metabolism, liver regeneration, neurotransmitter synthesis, and cardiovascular health.
Phosphatidylcholine therapy involves intravenous delivery of this essential phospholipid. PC is the primary structural component of cell membranes. Beyond structure, it supports fat metabolism, liver regeneration, neurotransmitter synthesis, and cardiovascular health. Its amphipathic nature lets it interact with cholesterol and fatty deposits in blood vessels to aid natural removal and circulation.
This therapy is used to support vascular function and has a long track record in European cardiovascular medicine.
Why this matters
PC supports both structure and function: membranes, lipids, liver, cognition, and vascular health.
PC integrates into atherosclerotic plaque within arterial walls, making rigid cholesterol deposits more fluid and susceptible to lipolytic processes and macrophage clearance. This can reduce plaque burden and improve flexibility.
PC strengthens cell membranes body-wide, improving fluidity, permeability, and receptor function. This supports nutrient uptake, waste removal, and communication across cells.
PC is a precursor for acetylcholine synthesis which supports memory, learning, and cognitive function.
PC supports hepatocyte regeneration, aids fat metabolism, and protects against non-alcoholic fatty liver conditions.
Potential arterial plaque reduction and better vessel flexibility
Enhanced endothelial function and circulation
Optimized liver function and fat metabolism
Improved lipid profile with lower LDL and higher HDL
Stronger cellular membranes across tissues
Better cognitive performance and memory
Timing varies by baseline status and protocol cadence.
Most patients tolerate PC infusions very well. Many read, work on devices, or relax during the session. Effects are progressive across a series.
Cardiovascular review and vitals. Establish IV access and confirm protocol and rate.
Slow PC infusion over 60 to 90 minutes in a reclining chair. Mild warmth or slight nausea may occur early and usually diminishes with subsequent sessions.
Resume normal activities after treatment. Occasional mild fatigue resolves with rest.
Standard protocols involve 10-30 sessions depending on cardiovascular status, plaque burden, and goals. Typically build with 1-3 infusions weekly, then transition to monthly maintenance.
Ready to support vascular and membrane health?
Explore how Phosphatidylcholine Therapy can support your cardiovascular health and cellular function optimization.
Please bring: Recent lipid panel, cardiovascular test results, current medications, family cardiovascular history.
Online Booking Available